Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study

B. M. Ances, J. J. Christensen, M. Teshome, J. Taylor, C. Xiong, P. Aldea, A. M. Fagan, D. M. Holtzman, J. C. Morris, M. A. Mintun, Clifford

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


Objectives: Diagnostic challenges exist for differentiating HIV dementia from Alzheimer disease (AD) in older HIV-infected (HIV+) individuals. Similar abnormalities in brain amyloid-β42 (Aβ42) metabolism may be involved in HIV-associated neuropathology and AD. We evaluated the amyloid-binding agent C-Pittsburgh compound B (C-PiB), a biomarker for Aβ42 deposition, in cognitively unimpaired HIV+ (n = 10) participants and matched community controls without dementia (n = 20). Methods: In this case-control study, all participants had an C-PiB scan within 2 years of concomitant CSF studies and neuropsychometric testing. Statistical differences between HIV+ and community controls for demographic and clinical values were assessed by χ tests. Participants were further divided into either low (<500 pg/mL) or normal (≥500 pg/mL) CSF Aβ42 groups with Student t tests performed to determine if regional differences in fibrillar amyloid plaque deposition varied with CSF Aβ42. Results: Regardless of CSF Aβ42 level, none of the HIV+ participants had fibrillar amyloid plaques as assessed by increased C-PiB mean cortical binding potential (MCBP) or binding potential within 4 cortical regions. In contrast, some community controls with low CSF Aβ42 (<500 pg/mL) had high C-PiB MCBP with elevated binding potentials (>0.18 arbitrary units) within cortical regions. Conclusions: Cognitively unimpaired HIV+ participants, even with low CSF Aβ42 (<500 pg/mL), do not have C-PiB parameters suggesting brain fibrillar amyloid deposition. The dissimilarity between unimpaired HIV+ and preclinical AD may reflect differences in Aβ42 production and/or formation of diffuse plaques. Future longitudinal studies of HIV+ participants with low CSF Aβ42 and normal C-PiB are required.

Original languageEnglish
Pages (from-to)111-115
Number of pages5
Issue number2
StatePublished - Jul 13 2010


Dive into the research topics of 'Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study'. Together they form a unique fingerprint.

Cite this